141 related articles for article (PubMed ID: 3043779)
1. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC
Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779
[TBL] [Abstract][Full Text] [Related]
2. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
[TBL] [Abstract][Full Text] [Related]
4. Kidney retransplantation in the cyclosporine era.
Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
[TBL] [Abstract][Full Text] [Related]
5. Multiple drug combinations with "low-dose" cyclosporin for renal transplantation. Multivariate analysis of risk factors determining short-term graft survival within one renal transplant center.
Hiesse C; Prevost P; Busson M; Lantz O; Cantarovich M; Bellamy J; Benoit G; Charpentier B; Fries D
Transpl Int; 1988 Oct; 1(3):149-54. PubMed ID: 3075474
[TBL] [Abstract][Full Text] [Related]
6. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
8. Early graft function.
Toyotome A; Terasaki PI; Salvatierra O; Starzl T; Hakala T; Kahan B; Diethelm A; Najarian J; Wolf J; Butt K
Clin Transpl; 1987; ():435-52. PubMed ID: 3154444
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing cadaver kidney transplantation outcome in the cyclosporine era. The North Italy Transplant Program (NITp).
Clin Transpl; 1988; ():131-45. PubMed ID: 3154466
[TBL] [Abstract][Full Text] [Related]
10. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
11. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
12. The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine.
Miwa H; Van Loenen M; Vanderwerf BA
Clin Transpl; 1989; ():275-80. PubMed ID: 2487572
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
14. Two decades of experience with cyclosporine in renal transplantation in Helsinki.
Salmela KT; Kyllönen LE
Transplant Proc; 2004 Mar; 36(2 Suppl):94S-98S. PubMed ID: 15041315
[TBL] [Abstract][Full Text] [Related]
15. Preservation.
Ito T; Iwaki Y; Terasaki PI
Clin Transpl; 1986; ():299-310. PubMed ID: 3154422
[TBL] [Abstract][Full Text] [Related]
16. An analysis of predictors of long-term cadaveric renal allograft survival.
Cole E; Naimark D; Aprile M; Wade J; Cattran D; Pei Y; Fenton S; Robinette M; Zaltsman J; Bear R
Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
[TBL] [Abstract][Full Text] [Related]
17. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
[TBL] [Abstract][Full Text] [Related]
18. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
19. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
20. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
